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CASE REPORT
A 45-year-old male presented with sensation of fullness after meals with vomiting since 4 months and anorexia with weight loss since 2 months. Patient was chronic smoker since 25 years and occasionally consumed alcohol.Upper gastrointestinal endoscopy (UGIE) revealed an ulcer at incissura on lesser curvature [ 
DISCUSSION
Gastric cancer is the fourth most commonly diagnosed cancer and is the second leading cause of cancer death worldwide [1] . Although survival of patients with gastric cancer after surgery has been improved by early detection and curative surgery, the prognosis of patients with highly advanced gastric cancer is usually very poor [2] . The majority of patients presenting with resectable gastric adenocarcinoma will have locally advanced disease [defined as the penetration ofthe subserosa by the primary tumour (T3), regional nodalinvolvement (N+), or both] for which the chance of cure with surgery alone is poor [3] .
Chemotherapy is the treatment of choice for metastatic advanced gastric cancer; however, a standard treatment regimen has not been established. Neoadjuvant chemotherapy for advanced gastric cancer with or without distant metastasis has been reported [4] . However pathological complete response rate is still lower than 8%. Anticipated benefits of Neoadjuvant chemotherapy are increase in likelihood of curative resection by downstaging tumour, elimination of micrometastases, improvement of tumour related symptoms, increased overall survival [5] .
CONCLUSION
Combination neoadjuvant chemotherapy with EOX regimen showed marked efficacy in treatment with pathological complete response in a case of locally advanced carcinoma stomach. After 5 cycles of EOX regimen of neoadjuvant chemotherapy, CT whole abdomen and barium meal post chemotherapy were normal. When patient was fit for surgery radical subtotal gastrectomy with modified D2 dissection was done with Bilroth II anastomosis. Aim of surgical resection was to confirm complete response by pathological examination and to provide therapeutic effects of resection if residual cancer cells were present.
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Pathologic complete response was defined as fibrosis or fibroinflammation within an entirely submitted and evaluated gross lesion without microscopic evidence of carcinoma, and histologically negative nodes [4] .
Pathological complete response was observed in our case following surgery with no evidence of malignancy in resected stomach specimen and presence of reactive lymphadenitis in all lymph nodes.
Pathological complete response has been reported in metastatic gastric cancers also with incurable factors such as peritoneal dissemination, hepatic metastases [7] . Thus, Can neoadjuvant
